FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2216442073> ?p ?o ?g. }

• W2216442073 abstract "Immuno-PET imaging of the tumor antigen HER2/neu allows for the noninvasive detection and monitoring of oncogene expression; such detection and monitoring are of prognostic value in patients with breast cancer. Compared with the full-size antibody trastuzumab, smaller protein tracers with more rapid blood clearance permit higher imaging contrast at earlier time points. Antigen-binding fragments (Fabs) of antibodies with moderately prolonged circulation achieved through the genetic fusion with a long, conformationally disordered chain of the natural amino acids Pro, Ala, and Ser (PASylation)-a biologic alternative to chemical conjugation with polyethylene glycol, PEG-offer a promising tracer format with improved pharmacokinetics for in vivo imaging. Recently, the transition metal radionuclide (89)Zr has attracted increasing interest for immuno-PET studies, complementing the conventional halogen radionuclide (124)I.To allow direct comparison of these 2 radioactive labels for the same protein tracer, the recombinant αHER2 Fab fused with 200 Pro, Ala, and Ser (PAS200) residues was either conjugated with (124)I via an iodination reagent or coupled with deferoxamine (Df) and complexed with (89)Zr. After confirmation of the stability of both radioconjugates and quality control in vitro, immuno-PET and biodistribution studies were performed with CD1-Foxn1(nu) mice bearing HER2-positive human tumor xenografts.(89)Zr⋅Df-Fab-PAS200 and (124)I-Fab-PAS200 showed specific tumor uptake of 11 and 2.3 percentage injected dose per gram 24 h after injection, respectively; both led to high tumor-to-blood (3.6 and 4.4, respectively) and tumor-to-muscle (20 and 43, respectively) ratios. With regard to off-target accumulation, overt (124)I activity was seen in the thyroid, as expected, whereas high kidney uptake was evident for (89)Zr; the latter was probably due to glomerular filtration and reabsorption of the protein tracer in proximal tubular cells.Both (89)Zr- and (124)I-labeled versions of αHER2 Fab-PAS200 allowed PET tumor imaging with high contrast. With its residualizing radiometal, the tracer (89)Zr⋅Df-Fab-PAS200 showed better in vivo stability and higher tumor uptake." @default.
• W2216442073 created "2016-06-24" @default.
• W2216442073 creator A5000481071 @default.
• W2216442073 creator A5011109417 @default.
• W2216442073 creator A5025735412 @default.
• W2216442073 creator A5051959238 @default.
• W2216442073 creator A5066579865 @default.
• W2216442073 date "2015-05-21" @default.
• W2216442073 modified "2023-10-02" @default.
• W2216442073 title "89Zr-Labeled Versus 124I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo" @default.
• W2216442073 cites W1972071526 @default.
• W2216442073 cites W1973188134 @default.
• W2216442073 cites W1987362747 @default.
• W2216442073 cites W2017773761 @default.
• W2216442073 cites W2032613674 @default.
• W2216442073 cites W2040531770 @default.
• W2216442073 cites W2041850633 @default.
• W2216442073 cites W2044725209 @default.
• W2216442073 cites W2082717401 @default.
• W2216442073 cites W2085607173 @default.
• W2216442073 cites W2111333477 @default.
• W2216442073 cites W2115269770 @default.
• W2216442073 cites W2122767481 @default.
• W2216442073 cites W2128957254 @default.
• W2216442073 cites W2129922868 @default.
• W2216442073 cites W2130870133 @default.
• W2216442073 cites W2135593703 @default.
• W2216442073 cites W2147316061 @default.
• W2216442073 cites W2154162767 @default.
• W2216442073 cites W2155338471 @default.
• W2216442073 cites W2160499123 @default.
• W2216442073 cites W2161892929 @default.
• W2216442073 cites W2162719553 @default.
• W2216442073 cites W2162841866 @default.
• W2216442073 cites W2162967244 @default.
• W2216442073 cites W2174939397 @default.
• W2216442073 cites W2318003234 @default.
• W2216442073 cites W4234475595 @default.
• W2216442073 doi "https://doi.org/10.2967/jnumed.114.149690" @default.
• W2216442073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25999431" @default.
• W2216442073 hasPublicationYear "2015" @default.
• W2216442073 type Work @default.
• W2216442073 sameAs 2216442073 @default.
• W2216442073 citedByCount "49" @default.
• W2216442073 countsByYear W22164420732015 @default.
• W2216442073 countsByYear W22164420732016 @default.
• W2216442073 countsByYear W22164420732017 @default.
• W2216442073 countsByYear W22164420732018 @default.
• W2216442073 countsByYear W22164420732019 @default.
• W2216442073 countsByYear W22164420732020 @default.
• W2216442073 countsByYear W22164420732021 @default.
• W2216442073 countsByYear W22164420732022 @default.
• W2216442073 countsByYear W22164420732023 @default.
• W2216442073 crossrefType "journal-article" @default.
• W2216442073 hasAuthorship W2216442073A5000481071 @default.
• W2216442073 hasAuthorship W2216442073A5011109417 @default.
• W2216442073 hasAuthorship W2216442073A5025735412 @default.
• W2216442073 hasAuthorship W2216442073A5051959238 @default.
• W2216442073 hasAuthorship W2216442073A5066579865 @default.
• W2216442073 hasBestOaLocation W22164420731 @default.
• W2216442073 hasConcept C112705442 @default.
• W2216442073 hasConcept C150903083 @default.
• W2216442073 hasConcept C159654299 @default.
• W2216442073 hasConcept C177322064 @default.
• W2216442073 hasConcept C185592680 @default.
• W2216442073 hasConcept C202751555 @default.
• W2216442073 hasConcept C203014093 @default.
• W2216442073 hasConcept C207001950 @default.
• W2216442073 hasConcept C2775842073 @default.
• W2216442073 hasConcept C2777807558 @default.
• W2216442073 hasConcept C29331040 @default.
• W2216442073 hasConcept C2989005 @default.
• W2216442073 hasConcept C55493867 @default.
• W2216442073 hasConcept C71924100 @default.
• W2216442073 hasConcept C86803240 @default.
• W2216442073 hasConcept C98274493 @default.
• W2216442073 hasConceptScore W2216442073C112705442 @default.
• W2216442073 hasConceptScore W2216442073C150903083 @default.
• W2216442073 hasConceptScore W2216442073C159654299 @default.
• W2216442073 hasConceptScore W2216442073C177322064 @default.
• W2216442073 hasConceptScore W2216442073C185592680 @default.
• W2216442073 hasConceptScore W2216442073C202751555 @default.
• W2216442073 hasConceptScore W2216442073C203014093 @default.
• W2216442073 hasConceptScore W2216442073C207001950 @default.
• W2216442073 hasConceptScore W2216442073C2775842073 @default.
• W2216442073 hasConceptScore W2216442073C2777807558 @default.
• W2216442073 hasConceptScore W2216442073C29331040 @default.
• W2216442073 hasConceptScore W2216442073C2989005 @default.
• W2216442073 hasConceptScore W2216442073C55493867 @default.
• W2216442073 hasConceptScore W2216442073C71924100 @default.
• W2216442073 hasConceptScore W2216442073C86803240 @default.
• W2216442073 hasConceptScore W2216442073C98274493 @default.
• W2216442073 hasLocation W22164420731 @default.
• W2216442073 hasLocation W22164420732 @default.
• W2216442073 hasOpenAccess W2216442073 @default.
• W2216442073 hasPrimaryLocation W22164420731 @default.
• W2216442073 hasRelatedWork W1966335626 @default.
• W2216442073 hasRelatedWork W1977290575 @default.
• W2216442073 hasRelatedWork W2017307891 @default.
• W2216442073 hasRelatedWork W2044725209 @default.

• next